Through evidence we aim to demonstrate the value of healthcare technologies, to maximize pricing and reimbursement opportunities for our Clients and to support technology innovation for the healthcare system.
Through evidence we aim to demonstrate the value of healthcare technologies, to maximize pricing and reimbursement opportunities for our Clients and to support technology innovation for the healthcare system.
Due to the constant evolution and increasing complexity in healthcare treatment paradigms, clinical and economic issues require thorough analysis and cross-functional approach, in order to seize market opportunities and optimize access.
With its strong scientific expertise and its focus on evidence understanding and analytical accuracy, EBMA is a trusted advisor team, helping Clients to understand key drivers for stakeholders’ choices, translating data into evidence, and supporting the right strategic decisions.
EBMA team, with broad experience in pharma, biotech and medical devices fields, provides comprehensive consulting services oriented to the creation of ad hoc solutions for clients’ challenges.
Our team is eager to help companies build actionable and bespoke projects and plans, in order to formulate solutions to overcome market access challenges and support successful commercialization throughout Europe and Canada.
Over the years, we have served several pharmaceutical companies in Italy, Europe and US.
We are an Italian consulting group with local and global capabilities
10+ years Consulting + 5 years Pharma Company
Chemistry M. Sc.; Pharmacoeconomics M. Sc.
4y consulting + 2y medical device company
Biomedical Eng. M. Sc.; Healthcare Mgmt. M. Sc.
2y consulting
Statistics M. Sc.
2y consulting + 10 years academic research
Pharmacist
1y consulting + 1 year public sector
Economist; International Health M. A.
For large-scope and multi-disciplinary projects, EBMA partners with other consulting groups, market research agencies, and a network of targeted experts.
EBMA supports companies in activities covering the areas of Strategy and Operations, with a strong focus on the first phases of product lifecycle.
LANDSCAPE ANALYSIS
Market Access & Reimbursement Landscape Analysis
Competitive Environment Analysis
Analogue Research
PRODUCT STRATEGY
Therapeutic Positioning Strategy
Pricing Strategy
Market Access Strategy
Early asset evaluation
Profit & Loss Analysis
MARKET ACCESS
Early Market Access Activities
Market Access Plan
FORECASTING & LAUNCH PLANNING
Financial Forecasting
International Referencing Pricing Analysis
SKU Optimization Analysis
EVIDENCE GENERATION
Outcome Research
Health Economic Analyses
VALUE COMMUNICATION
Value Dossier Development
Negotiation Tools Set-up
Evidence Communication
PREPARATION OF P&R SUBMISSION AND NEGOTIATION
Early Advice Activities
Health Economic Model Customization
P&R Dossier Development
Negotiation strategy
Critical Revisions of Models and HTA Submissions (e.g. NICE, SMC)
We aim to provide our Clients with a comprehensive, strategic and operational support, to successfully secure market access in EU and set the basis to reach their commercial objectives.
Our project solutions are tailored to the Client’s needs and designed to target their specific business objectives